SUMMA
The goal of the Stanford University Minority Medical Alliance (SUMMA) Conference is to equip premedical and pre-health students with tools to apply to medical school and other health training programs. The SUMMA Conference was founded in 1990 by our SUMMA medical students to better care for underserved communities. Our annual pre-health conference is one of the oldest on the West Coast and draws hundreds of students from throughout California and the nation. The SUMMA Conference is open to all students from all backgrounds interested in pursuing a career in medicine to address health inequities.
35th Annual Stanford University Minority Medical Alliance (SUMMA) Conference
The conference will be held in person Saturday, February 7, 2026!
Registration for the SUMMA 2026 Conference will open in the Fall.
Please stay tuned to this website for conference updates.
Follow ODME
SUMMA is a coalition of Stanford medical students, including representatives from:
- Asian Pacific American Medical Student Association (APAMSA)
- First-Generation and/or Low-Income @ Stanford Medical School (FLI@SMS)
- Jewish Medical Student Association (JMSA)
- Latino Medical Student Association (LMSA)
- LGBTQ-Meds
- Medical Students with Disability and Chronic Illness (MSDCI)
- Muslim Medical Association (SMMA)
- Middle Eastern and North African Students in Medicine (MENAMeds)
- Stanford American Indigenous Medical Students (SAIMS)
- Student National Medical Association (SNMA)
Learn more about these student associations
Together, we provide support to Stanford's medical students as they work toward their degrees and to a future in health care with better outcomes for all patients.
SUMMA 2025 Poster Submissions
Renee Abouem SUMMA Poster Submission 2025
Advancing Towards a Meningitis-Free African Region by 2030: Regional Implementation Framework to Defeat Meningitis.
Mohammadamin Mahmanzar SUMMA Poster Submission 2025
What the Health!?
Ana Rumbaut SUMMA Poster Submission 2025
COX-2 upregulation in astrocytes of a Parkinson's mouse model: Exploring drug repurposing in pursuit of treatment accessibility
Ajaypal Sahota SUMMA Poster Submission 2025
A novel Shc Inhibitor Shc301 Attenuates cGVHD in a Murine Mouse Model